Moderna stock returns 713% in a year, closing at $258.38
The gist
Moderna stock returned 713.1% in the year to November 2, 2026, versus 11.5% for the S&P 500.
The rally rests on a melanoma vaccine trial, while Q3 earnings land November 6.
How it unfolded
- Nov 20, 2025Moderna stock closed at a low of $22.36.
- Jun 2026Moderna posted a net loss of $3.15 billion over the four quarters to June 2026.
- Jul 2026Moderna paid $950 million under a litigation settlement.
Key terms
- S&P 500
- A stock market index tracking the performance of 500 large US companies listed on American exchanges.
- Phase III
- A late stage of clinical research testing a treatment's effectiveness in many participants after early safety testing.
Source: Wikipedia